Stavros Topouzis

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Health Insurance

Mesenchymal Stem Cells

Chemotherapy Induced

Top Venues

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Papapetropoulos, Stavros Topouzis, Stephen P H Alexander, Miriam M Cortese-Krott, Dave A Kendall, Kirill A Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A Panettieri, Hemal H Patel, Rainer Schulz, Barbara Stefanska, Gary J Stephens, Mauro Martins Texeira, Nathalie Vergnolle, Shunyao Wang, Peter Ferdinandy
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review. British journal of pharmacology 181 (11) (2024)
Andreas Papapetropoulos, Stavros Topouzis, Stephen P H Alexander, Miriam M Cortese-Krott, Dave A Kendall, Kirill A Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A Panettieri, Hemal H Patel, Rainer Schulz, Barbara Stefanska, Gary J Stephens, Mauro Martins Texeira, Nathalie Vergnolle, Shunyao Wang, Peter Ferdinandy
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review. British journal of pharmacology (2024)
Andreas Papapetropoulos, Stavros Topouzis, Stephen P H Alexander, Miriam M Cortese-Krott, Dave A Kendall, Kirill A Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A Panettieri, Hemal H Patel, Rainer Schulz, Barbara Stefanska, Gary J Stephens, Mauro Martins Texeira, Nathalie Vergnolle, Shunyao Wang, Peter Ferdinandy
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review. British journal of pharmacology 181 (11) (2024)